A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema
Clinical trial NCT04030598 · COMPLETED
Trial details
- NCT number
- NCT04030598
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2021-01-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.